These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34923970)

  • 21. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.
    Korczak D; Dietl M; Steinhauser G
    GMS Health Technol Assess; 2011 Apr; 7():Doc02. PubMed ID: 21468290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Falls prevention for the elderly.
    Balzer K; Bremer M; Schramm S; Lühmann D; Raspe H
    GMS Health Technol Assess; 2012; 8():Doc01. PubMed ID: 22536299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges.
    Hill SR; Vale L; Hunter D; Henderson E; Oluboyede Y
    Health Policy; 2017 Dec; 121(12):1249-1262. PubMed ID: 29100609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Prevention Pay? Costs and Potential Cost-savings of School Interventions Targeting Children with Mental Health Problems.
    Wellander L; Wells MB; Feldman I
    J Ment Health Policy Econ; 2016 Jun; 19(2):91-101. PubMed ID: 27453456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the cost-effectiveness of prevention.
    Banta HD; Luce BR
    J Community Health; 1983; 9(2):145-65. PubMed ID: 6430973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.
    Saha S; Hoerger TJ; Pignone MP; Teutsch SM; Helfand M; Mandelblatt JS;
    Am J Prev Med; 2001 Apr; 20(3 Suppl):36-43. PubMed ID: 11306230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic impact of two diagnostic strategies in the management of restorations in primary teeth: a health economic analysis plan for a trial-based economic evaluation.
    Freitas RD; Moro BLP; Pontes LRA; Maia HCM; Passaro AL; Oliveira RC; Garbim JR; Vigano MEF; Tedesco TK; Deery C; Raggio DP; Cenci MS; Mendes FM; Braga MM;
    Trials; 2021 Nov; 22(1):794. PubMed ID: 34772437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services.
    Carande-Kulis VG; Maciosek MV; Briss PA; Teutsch SM; Zaza S; Truman BI; Messonnier ML; Pappaioanou M; Harris JR; Fielding J
    Am J Prev Med; 2000 Jan; 18(1 Suppl):75-91. PubMed ID: 10806980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considering economic analyses in the revision of the preventive vaccination law: a new direction for health policy-making in Japan?
    Akazawa M; Yongue J; Ikeda S; Satoh T
    Health Policy; 2014 Oct; 118(1):127-34. PubMed ID: 25139708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do government health departments in Australia access health economics advice to inform decisions for health? A survey.
    Madden L; King L; Shiell A
    Aust New Zealand Health Policy; 2009 Apr; 6():6. PubMed ID: 19358711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive overview and qualitative analysis of government-led nutrition policies in Australian institutions.
    Rosewarne E; Hoek AC; Sacks G; Wolfenden L; Wu J; Reimers J; Corben K; Moore M; Ni Mhurchu C; Webster J
    BMC Public Health; 2020 Jun; 20(1):1038. PubMed ID: 32605547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations.
    Trapero-Bertran M; Pokhrel S; Hanney S
    Health Res Policy Syst; 2022 Jun; 20(1):67. PubMed ID: 35717247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical review of health-related economic evaluations in Australia: implications for health policy.
    Salkeld G; Davey P; Arnolda G
    Health Policy; 1995 Feb; 31(2):111-25. PubMed ID: 10141252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.
    Henry D
    Pharmacoeconomics; 1992 Jan; 1(1):54-67. PubMed ID: 10147039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.